Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
OS Therapies unit OS Animal Health gets USDA feedback on conditional licensure path for OST-HER2 in canine osteosarcoma

OS Therapies unit OS Animal Health gets USDA feedback on conditional licensure path for OST-HER2 in canine osteosarcoma

BitgetBitget2026/10/07 12:33

OS Therapies’ animal health unit, OS Animal Health, received USDA feedback on the regulatory pathway for OST-HER2 in canine osteosarcoma. Guidance covered clinical efficacy, safety, non-clinical requirements, and CMC ahead of a planned conditional licensure request. OS Animal Health targets a 2027 U.S. commercial launch; expects additional studies to support full USDA licensure. OS Therapies is weighing strategic or capital alternatives to monetize OS Animal Health for shareholder benefit. OS Animal Health plans a Q4 2026 crowdfunding to broaden ownership ahead of a potential U.S. exchange listing. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610070830NEWSFILECNPR____20261007_317856_1) on October 07, 2026, and is solely responsible for the information contained therein.

  • OS Therapies’ animal health unit, OS Animal Health, received USDA feedback on the regulatory pathway for OST-HER2 in canine osteosarcoma.
  • Guidance covered clinical efficacy, safety, non-clinical requirements, and CMC ahead of a planned conditional licensure request.
  • OS Animal Health targets a 2027 U.S. commercial launch; expects additional studies to support full USDA licensure.
  • OS Therapies is weighing strategic or capital alternatives to monetize OS Animal Health for shareholder benefit.
  • OS Animal Health plans a Q4 2026 crowdfunding to broaden ownership ahead of a potential U.S. exchange listing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610070830NEWSFILECNPR____20261007_317856_1) on October 07, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high

Japan's spot electricity prices surged to multi-year highs over the weekend.

智通财经•2026/11/09 08:07
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high

Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail

Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

智通财经•2026/11/09 07:32
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail